Prevalence of Thromboembolic Events in Patients With Non–Small Cell Lung Cancer and RET Fusions
Authors:
- 1 November 2023
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 9 (11) , 1583-1584
Abstract
This cohort study examines the incidence, risks, and characteristics of deep vein thrombosis, pulmonary embolism, arterial thrombosis, and stroke among patients with non–small cell lung cancer (NSCLC) and RET fusions.Keywords
This publication has 6 references indexed in Scilit:
- RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET FusionJournal of Thoracic Oncology, 2023
- Cancer-associated venous thromboembolismNature Reviews Disease Primers, 2022
- Precision therapy for RET-altered cancers with RET inhibitorsTrends in Cancer, 2021
- Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare dataBritish Journal of Cancer, 2016
- Translational Lung Cancer Research2016
- High Risk of Deep Vein Thrombosis in Patients with Non-small Cell Lung Cancer: A Cohort Study of 493 PatientsJournal of Thoracic Oncology, 2007